HomePRLD • NASDAQ
add
Prelude Therapeutics Inc
Previous close
$3.30
Day range
$3.24 - $3.70
Year range
$0.61 - $4.22
Market cap
211.69M USD
Avg Volume
323.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 5.64M | 41.00% |
Operating expense | 21.69M | -42.67% |
Net income | -16.46M | 42.72% |
Net profit margin | -291.79 | 59.38% |
Earnings per share | -0.20 | 45.95% |
EBITDA | -15.63M | 53.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.21M | -22.75% |
Total assets | 141.32M | -19.49% |
Total liabilities | 72.68M | 64.97% |
Total equity | 68.64M | — |
Shares outstanding | 82.53M | — |
Price to book | 3.98 | — |
Return on assets | -33.99% | — |
Return on capital | -49.28% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -16.46M | 42.72% |
Cash from operations | 23.12M | 211.45% |
Cash from investing | -60.34M | -372.80% |
Cash from financing | 24.94M | 73,464.71% |
Net change in cash | -12.28M | -1,016.12% |
Free cash flow | 27.91M | 314.50% |
About
Founded
2016
Headquarters
Website
Employees
79
